Original language | English |
---|---|
Pages (from-to) | 158-160 |
Number of pages | 3 |
Journal | Vaccine |
Volume | 31 |
Issue number | SUPPL.8 |
DOIs |
|
State | Published - 22 Nov 2013 |
Bibliographical note
Funding Information:The work of F. Xavier Bosch and Mireia Diaz, was partially supported by public grants from the European Commission (7th Framework Programme grant HEALTH-F3-2010-242061, PREHDICT), from the Instituto de Salud Carlos III (Spanish Government) (grants FIS PI10/02995, RCESP C03/09, RTICESP C03/10, RTIC RD06/0020/0095, RD12/0036/0056 and CIBERESP) and from the Agència de Gestió d’Ajuts Universitaris i de Recerca – Generalitat de Catalunya (Catalonian Government) (grants AGAUR 2005SGR00695 and AGAUR 2009SGR126) who had no role in data collection, analysis or interpretation of results.
Funding Information:
WAF: Has received consultant, travel, and research funding from Merck Canada.
Funding
The work of F. Xavier Bosch and Mireia Diaz, was partially supported by public grants from the European Commission (7th Framework Programme grant HEALTH-F3-2010-242061, PREHDICT), from the Instituto de Salud Carlos III (Spanish Government) (grants FIS PI10/02995, RCESP C03/09, RTICESP C03/10, RTIC RD06/0020/0095, RD12/0036/0056 and CIBERESP) and from the Agència de Gestió d’Ajuts Universitaris i de Recerca – Generalitat de Catalunya (Catalonian Government) (grants AGAUR 2005SGR00695 and AGAUR 2009SGR126) who had no role in data collection, analysis or interpretation of results. WAF: Has received consultant, travel, and research funding from Merck Canada.
Funders | Funder number |
---|---|
CIBERESP | |
Catalonian Government | |
Seventh Framework Programme | HEALTH-F3-2010-242061 |
European Commission | |
Generalitat de Catalunya | |
Agència de Gestió d'Ajuts Universitaris i de Recerca | 2009SGR126, 2005SGR00695 |
Instituto de Salud Carlos III | FIS PI10/02995, RCESP C03/09, RD12/0036/0056, RTIC RD06/0020/0095, RTICESP C03/10 |
Merck Canada |